RxDoctor Payments Data

Stephanie Cook, NP

Nurse Practitioner · Alexandria, VANPI 1437757960

Payments from drug & device makers

$715in general payments, 2019–2025

Across 35 payments — averaging $20.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$159
  • E.r. Squibb & Sons, L.L.C.$114
  • Amgen$66
  • Pfizer$50
  • Boehringer Ingelheim$47
  • Actelion Pharmaceuticals US, Inc.$33
  • plus $246 from 11 others

What the payments were for

  • Food & beverage$715100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$715 in reported general payments places this provider in the 80th percentile of 2,166 nurse practitioner providers in Virginia.

See all nurse practitioner providers in Virginia

Medicare billing

Part B allowed, 2024
$2,904
Medicare patients
26
Services billed
52

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban79$86,431
EntrestoSacubitril/Valsartan20$38,055
JardianceEmpagliflozin12$11,525
BrilintaTicagrelor11$4,880
Metoprolol Succinate74$1,137
Atorvastatin Calcium87$1,110
Rosuvastatin Calcium31$523
Ezetimibe16$449
Furosemide68$432
Losartan Potassium43$405
Hydralazine Hcl34$367
Carvedilol36$324
Valsartan14$324
Bumetanide14$286
Amlodipine Besylate25$265

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$50$86,43179 claims
NovartisEntresto$159$38,05520 claims
Boehringer IngelheimJardiance$47$11,52512 claims
AstraZenecaBrilinta$17$4,88011 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,166 nurse practitioner providers in Virginia.

Other nurse practitioner in Alexandria

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →